Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Presents Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Phibro Animal Health (PAHC) Misses Q4 EPS by 3c, Revenues Misss; Provides FY20 EPS Guidance Below Consensus
August 27, 2019 4:18 PM EDTPhibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.33, $0.03 worse than the analyst estimate of $0.36. Revenue for the quarter came in at $204 million versus the consensus estimate of $206 million.
Highlights for the June 2019 quarter (compared to the June 2018 quarter)
Net sales of $204 million, a decrease of $8 million, or 4%Net income of $9 million, a decrease of $13 million, or 60%Diluted EPS of $0.22, a decrease of $0.33, or 60%Adjusted EBITDA of $26 million, a decrease of $7 million, or 20%Adjusted diluted EPS of $0.33, a decrease of $0.13, or... More